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Abstract
Background: The International Fetal and Newborn Growth Consortium for the 21st
Century (INTERGROWTH-21st) Project is a population-based, longitudinal study
describing early growth and development in an optimally healthy cohort of 4607
mothers and newborns. At 24 months, children are assessed for
neurodevelopmental outcomes with the INTERGROWTH-21st Neurodevelopment
Package. This paper describes neurodevelopment tools for preschoolers and the
systematic approach leading to the development of the Package.
Methods: An advisory panel shortlisted project-specific criteria (such as multi-
dimensional assessments and suitability for international populations) to be fulfilled
by a neurodevelopment instrument. A literature review of well-established tools for
preschoolers revealed 47 candidates, none of which fulfilled all the project’s criteria.
A multi-dimensional assessment was, therefore, compiled using a package-based
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approach by: (i) categorizing desired outcomes into domains, (ii) devising domain-
specific criteria for tool selection, and (iii) selecting the most appropriate measure
for each domain.
Results: The Package measures vision (Cardiff tests); cortical auditory processing
(auditory evoked potentials to a novelty oddball paradigm); and cognition, language
skills, behavior, motor skills and attention (the INTERGROWTH-21st
Neurodevelopment Assessment) in 35–45 minutes. Sleep-wake patterns
(actigraphy) are also assessed. Tablet-based applications with integrated quality
checks and automated, wireless electroencephalography make the Package easy
to administer in the field by non-specialist staff. The Package is in use in Brazil,
India, Italy, Kenya and the United Kingdom.
Conclusions: The INTERGROWTH-21st Neurodevelopment Package is a multi-
dimensional instrument measuring early child development (ECD). Its
developmental approach may be useful to those involved in large-scale ECD
research and surveillance efforts.
Introduction
Approximately one in ten children have impairments in neurodevelopment,
which manifest as disturbances in cognition, auditory processing, vision,
behavior, language, attention, motor skills and sleep [1]. Research into the
epidemiology of childhood neurodisability has revealed three consistent global
trends. First, the prevalence of childhood neurodisability varies widely across
geographical locations with higher prevalences reported from low- and middle-
income countries (LMICs; 5.3 to 24.3 per 1,000 children) than high-income
countries (HICs; 2.0 to 4.5 per 1,000 children) [2]. Second, the reported
prevalence of mild levels of neurodisability is consistently higher than that of
severe neurodisability in both LMICs and HICs [2]. Third, the prevalence of
childhood neurodisability in LMICs is much more variable than in HICs. Among
HICs, rates of severe childhood neurodisability range between 2 and 5 per 1,000
children; in LMICs they range from 5.9 per 1,000 in Dhaka, Bangladesh to 24.3
per 1,000 in Karachi, Pakistan [2] (Fig. 1).
A number of genetic, biological and environmental risk factors, operating in the
pre- or postnatal period, or both, have been proposed [3]. These are summarized
in Table 1. More often than not, these factors do not act in isolation but interact
with each other resulting in a multi-factorial etiological matrix in which some, but
not all, risk factors may be modifiable. Irrespective of its precise etiological
determinants, childhood neurodisability is one of the most important precursors
of psychopathology, poor social functioning and educational disadvantage in later
life [3, 4]. Attention and behavior problems in early childhood have been
associated with higher rates of oppositional/defiant behavior, conduct problems,
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personality disorder, depression, antisocial lifestyles and suicide attempts in
adolescence and adulthood [4–7]. Longitudinal studies have also found children
with neurodisability to be less likely to be living independently, in paid
employment and have cohabitating relationships as adults compared to controls
[8]. These effects are most pronounced in those born extremely preterm, those
with very low birth weights (,1,000 g) and those with severe neurodevelopmental
impairments manifesting early in life [9, 10].
Despite the long-term significance of childhood neurodisability and benefit of
early diagnosis and treatment in young children, there is limited scientific and
clinical agreement on two issues central to the topic: (i) international standards of
optimal early child development (ECD) and (ii) standardized, internationally
applicable tools to measure these outcomes in young children [11, 12]. Although a
sizable body of literature on ECD and childhood neurodisability exists, there is
limited comparability among the many studies because of the heterogeneity in
methods employed in assessments, the wide ranges of ages assessed, and the focus
on specific domains of neurodevelopment rather than global outcomes [11, 12].
Two important reasons for this limited comparability among studies are the lack
of: (i) a standardized, robust methodology that is easy and rapid to administer in
the field, and that uses a combination of psychological, clinical and
neurophysiological tests to measure multiple dimensions of neurodevelopment,
and (ii) large, international, prospective cohorts on whom information about
potential risk and protective factors for ECD (such as fetal growth, home
environment, maternal health and early nutrition) is available.
Figure 1. Distribution of the prevalence of severe neurodevelopmental impairment per 1,000 children in select countries. Distribution of prevalence
of severe neurodevelopmental impairment per 1,000 children in select countries. Taken from Durkin, The Epidemiology of Developmental Disabilities in Low-
Income Countries, Mental Retardation and Developmental Disabilities Research Reviews p. 207 (2002) [2].
doi:10.1371/journal.pone.0113360.g001
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In the context of ECD research, it is important to highlight the many conceptual
and methodological challenges in investigating the epidemiology of neurodeve-
lopmental disturbances in young children in a large, international cohort (Fig. 2).
First, little is known about childhood neurodisability in LMICs despite the high
prevalence of risk factors. In addition, the children most at risk in these settings are
unlikely to have been assessed and, therefore, may not be represented in prevalence
estimates [2]. Second, although severe disorders may be recognized during infancy,
it is difficult to reliably diagnose impairments in speech, cognition or behavior
before 3 to 4 years of age [2]. Nevertheless, there is increasing evidence that the
earlier the identification and treatment of childhood neurodisability, the better the
opportunity for developmental change [2]. Third, the wide normal variation in
neurodevelopment among children, simultaneous delays in multiple areas of
development, and the logistic implications of carrying out long-term surveillance
makes the selection and implementation of an assessment complicated [13]. Fourth,
assessments that yield information of clinical prognostic importance are often
lengthy, require specialist training and contain culture-specific items making them
difficult to implement in the field, especially in international settings [2, 13]. Fifth,
studies employing neuroimaging and neurophysiological measurements (e.g.
electroencephalography, magnetoencephalography, functional magnetic resonance
imaging and eye tracking), although free from cultural biases and of sufficient
sensitivity to measure subtle differences in neurodevelopment, are often limited to
one domain, are resource intensive and are extremely difficult to implement in the
field and in very young children.
Table 1. Summary of major risk factors for early childhood neurodisability.
Major Risk factors for Early Childhood Neurodisability
Genetic Factors Biological Factors Environmental Factors
Prenatal Period N Chromosomal disorders N Poor intra-uterine growth N Exposure to teratogens, environmental toxins, and sub-
stances
N Gene disorders N Maternal infections
N Maternal exposure to abuse, conflicts & famines
N Intrauterine infections
N Maternal depression & anxiety
Birth Period - N Low birth weight N Birth trauma
N Preterm birth
N Birth asphyxia
Postnatal Period N Metabolic disorders N Under nutrition N Exposure to environmental toxins
N Vitamin deficiencies N Parental depression& mental health problems
N Congenital disorders
N Infections N Parenting behavior
N Malignancies N Child abuse and neglect




The INTERGROWTH-21st Project Neurodevelopment Package
PLOS ONE | DOI:10.1371/journal.pone.0113360 November 25, 2014 4 / 34
Background: The INTERGROWTH-21st Project
INTERGROWTH-21st (The International Fetal and Newborn Growth
Consortium for the 21st Century) is a multicenter, multiethnic, population-based
project, conducted between 2008 and 2013, in eight study sites: the cities of
Pelotas (Brazil), Turin (Italy), Muscat (Oman), Oxford (UK) and Seattle (USA);
Shunyi County, Beijing (China); the central area of Nagpur (India), and the
Parklands suburb of Nairobi (Kenya) [14]. Its primary aim was to study growth,
health, nutrition and neurodevelopment from ,14+0 weeks of gestation to 2 years
of age, using the same conceptual framework as the WHO Multicentre Growth
Reference Study [15], so as to produce prescriptive, international growth
standards and a new phenotypic classification of the intrauterine growth
restriction and preterm birth syndromes.
The women whose babies contributed to the construction of the international
standards describing optimal fetal and newborn growth were selected on the basis
of two factors: they were living in environments where the exposure to risk factors
known to affect fetal growth was minimal, and they themselves were healthy, non-
obese and similarly free of any factors or conditions affecting fetal growth. The
study methodology has been published elsewhere in detail [14]. In brief, clinical,
nutrition and anthropometric outcomes were measured in mothers and children
during pregnancy and at birth, during the first year of life, and at 24 months after
birth. The inclusion and exclusion criteria, study protocol, ultrasound manual and
other documents are available at www.intergrowth21.org.uk. The recruitment of a
large, optimally healthy, international, population-based sample; the use of
Figure 2. Conceptual and methodological challenges in the assessment of early child development in the context of the INTERGROWTH-21st
Project. Conceptual and methodological challenges in the multi-dimensional assessment of early childhood neurodevelopment across low-, middle- and
high-income settings (black boxes) and the unique opportunity provided by the INTERGROWTH-21st Project to explore some of these issues (red boxes).
doi:10.1371/journal.pone.0113360.g002
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robust, standardized procedures in all assessments (ultrasound, clinical and
anthropometric) including a system of random evaluation and repetition to
achieve quality control, and the use of a centralized data management system
make the INTERGROWTH-21st birth cohort distinct in its methodology and
scope.
In an extension to the 24 month follow-up of the INTERGROWTH-21st
Project, an assessment of early child neurodevelopment was included based on the
rationale that the Project provided a unique opportunity to profile neurodeve-
lopment outcomes in an optimally healthy sample of children whose nutritional
and health needs had been fully met during the first 1,000 days of life (Fig. 2). It is
envisioned that the data from this study will add to the current understanding of
neurodevelopment trajectories during early childhood by comparing different
neurodevelopment functions across a range of contexts and settings as well as
relating these functions to intrauterine growth. The Project also provided an
opportunity to develop and test a novel, mixed methodology, global approach to
the assessment of early child development using objective, robust techniques,
which are quick and easy to administer in both high- and low-resource settings by
non-professional staff.
Towards this end, a multi-dimensional, mixed methodology, screening package
to assess neurodevelopment in international populations of preschoolers was
developed. The Package was designed to be easy to administer in the field, in 35 to
45 minutes, by non-specialist research staff. In keeping with the methodology and
scope of the INTERGROWTH-21st Project, the Package was designed to measure
neurodevelopment in children in an ‘optimally healthy’ cohort in accordance with
the methodological concepts of standardization, integrated quality assessments
and centralized data management. The Package is in use in study sites in Brazil,
Kenya, India, Italy and the UK where more than 700 children have been assessed
to date. The objectives of this paper are to: (1) outline the methodology leading to
the development of the Package and the challenges involved in this process and
(2) describe the characteristics of the INTERGROWTH-21st Neurodevelopment
Package.
Materials and Methods
Study sites and participants
Five INTERGROWTH-21st Project sites are implementing the INTERGROWTH-
21st Neurodevelopment Package. These are the Universidade Federal de Pelotas,
Pelotas, Brazil; Aga Khan University Hospital, Nairobi, Kenya; Ketkar Hospital,
Nagpur, India; Universita’ di Torino, Turin, Italy; and the John Radcliffe Hospital,
Oxford, UK. A total of 4607 optimally healthy mothers were recruited from these
sites [16, 17], their characteristics are presented in Table 2 [17].
The INTERGROWTH-21st Project Neurodevelopment Package
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Ethics
Participants in the INTERGROWTH-21st Project were informed about the study
procedures, and voluntarily consented to participation. Written consent was
obtained from all adult participants. Parents/guardians provided written informed
consent on behalf of their children enrolled in the Project. Participants (or their
parents/guardians in the case of children) provided written consent for their
clinical records to be used in the Project. The INTERGROWTH-21st Project was
approved by the Universidade Federal de Pelotas, Faculdade de Medicina comiteˆ
de e´tica em pesquisa (Ref: OF.051/09), Beijing Obstetric and Gynaecology
Hospital, Capital Medical University; the Indian Council of Medical Research, the
Indian Ministry of Health and Family Welfare and the Institutional Ethics
Committee, Ketkar Hospital, Nagpur (Ref: 5/7/314/2008-RHN); Servizio
Sanitario Nazionale – Regione Piemonte, Aziende Ospedaliere OIRM/S.Anna,
Oridine Mauriziano di Torino, Comitato Etico Interaziendale (Ref: G9947/CEI/
C.27.2); the Aga Khan University Health Research Ethics Committee (Ref: AKU-
09-106), the Oman Research and Clinical Studies Committee (Ref: MH/DGHA/
DNCD/R&C/47/09), the Oxfordshire Research Ethics Committee ‘C’, United
Kingdom (Ref: 08/H0606/139) and the University of Washington, Human
Subjects Division, Human Subjects Review Committee (Ref: 36341).
Conceptual issues guiding the INTERGROWTH-21st Project
Neurodevelopment Assessment
Figure 2 illustrates the conceptual framework behind the rationale to include an
assessment of neurodevelopment in the INTERGROWTH-21st Project. Prior to
the selection of a neurodevelopment measure for the Project, an Infant
Development Group consisting of international experts in pediatric medicine,
pediatric neurology, child development, child psychology, neuroscience, electro-
encephalography, vision, obstetric medicine and epidemiology was constituted.
The Group’s remit was to review the cohort’s characteristics and the requirements
of the Project so as to develop a set of criteria for a neurodevelopment measure to
meet the Project’s needs (see Table 3). As a preliminary step, the Group identified
a number of conceptual, methodological and logistical challenges to the selection,
design or development of a neurodevelopment measure in a large, multi-site study
of young children. These are listed in Table 4.
Selection of a Neurodevelopment Tool for the INTERGROWTH-21st
Project
The Infant Development Group selected a measure of neurodevelopment at 24
months using two sequential approaches, and the results of approach 1 informed
the design and results of approach 2. The methods and results of each approach
are described in the sections that follow.
The INTERGROWTH-21st Project Neurodevelopment Package
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Approach 1: Review of existing psychometric tools for assessing
neurodevelopment at 24 months
The Infant Development Group compiled a list of the most well-established
psychometric tools to measure neurodevelopment outcomes, including (but not
limited to) cognition, language skills, motor skills and behavior, at 24 months in
an international sample. This age was selected as it was found to be the earliest at
which: (i) neurodevelopment is not confounded by transient neurological
syndromes of prematurity and (ii) conventionally used developmental instru-
ments, such as the Bayley Scales of Infant Development, have been found to
possess an acceptable level of medium and long term predictive validity [18]. The
list was compiled in two phases.
Table 2. Inclusion criteria to be met by mothers at booking for recruitment in the INTERGROWTH-21st Project.
Inclusion criteria for the INTERGROWTH-21st Project
Maternal Characteristics:
a) Age >18 and ,35 years
b) Body mass index >18.5 and ,30 kg/m2
c) Height >153 cm
d) Singleton pregnancy
e) A known date of the last menstrual period with regular cycles (defined as 28 days ¡4 days) without
hormonal contraceptive use, or breastfeeding in the 2 months before pregnancy
f) Natural conception
g) No relevant past medical history (refer to screening form), with no need for long term medication
(including fertility treatment and over-the-counter medicines, but excluding routine iron, folate, calcium,
iodine or multivitamin supplements)
h) No evidence of socio-economic constraints likely to impede fetal growth identified using local
definitions of social risk
i) No use of tobacco or recreational drugs such as cannabis in the 3 months before or after becoming
pregnant
j) No heavy alcohol use (defined as .5 units (50 ml pure alcohol) per week) since becoming pregnant
k) No more than one miscarriage in the 2 previous consecutive pregnancies
l) No previous baby delivered pre-term (,37 weeks) or with a birth weight ,2500 g or .4500 g
m) No previous neonatal or fetal death, previous baby with any congenital malformations, and no
evidence in present pregnancy of congenital disease or fetal anomaly
n) No previous pregnancy affected by pre-eclampsia/eclampsia, HELLP (Hemolysis, elevated liver
enzymes & low platelets) syndrome or a related pregnancy-associated condition
o) No clinically significant atypical red cell alloantibodies
p) Negative urinalysis
q) Systolic blood pressure ,140 mmHg and diastolic blood pressure ,90 mmHg
r) No diagnosis or treatment for anemia during this pregnancy
s) No clinical evidence of any other sexually transmitted diseases, including syphilis and clinical
Trichomoniasis
t) Not in an occupation with risk of exposure to chemicals or toxic substances, or very physically
demanding activity to be evaluated by local standards. Also women should not be conducting vigorous or
contact sports, as well as scuba diving or similar activities
doi:10.1371/journal.pone.0113360.t002
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Table 3. Criteria to be met by a neurodevelopment measure for inclusion in the INTERGROWTH-21st Project.
INTERGROWTH-21st Project criteria for a neurodevelopment measure
Essential criteria:
i. The measure must be suitable for assessing neurodevelopment in children at 2 years of age.
ii. The measure must be sufficiently sensitive to detect subtle differences in neurodevelopment in a largely
healthy cohort of children
iii. The measure must characterize neurodevelopmental outcomes in children across a spectrum ranging
from normal to mild, moderate and severe disturbances, and not assess severe neurodevelopmental delay
only.
iv. The measure must assess neurodevelopmental outcomes with the highest possible degree of objectivity
to minimize rate, reporter and cultural biases.
v. The measure must be suitable for use in HICs as well as LMICs, and must not contain items that are
culture-specific.
vi. The measure must assess multiple domains of neurodevelopment, including motor development,
cognition, language skills and behavior.
vii. The total duration of assessment for each individual child must not exceed 50 minutes.
viii. It must be easy to train local field workers to administer the tool and no specialist training in psychiatry,
psychology or related disciplines should be necessary.
Desirable criteria:
i. The tool should characterize the child’s performance on each item on a Likert-like scale yielding a range of
possible outcomes for each item rather than binary categorization of the child’s performance as pass or
fail.
ii. The tool should include a combination of methodologies for assessing infant neurodevelopment including
direct tests, parent reports and/or neurophysiological methods.
iii. If devised and tested in low resource settings in LMICs the tool should be appropriate for use in high-
income settings in the HICs as well as LMICs.
doi:10.1371/journal.pone.0113360.t003
Table 4. Challenges to the selection, design and development of a neurodevelopment assessment for use in
young children and in multiple international settings in the INTERGROWTH-21st Project.
Challenges in selection of a measure of early child development for the INTERGROWTH-21st
Project
Conceptual A range of neurodevelopmental outcomes should be measured to assess
simultaneous delays in multiple areas of neurodevelopment
Careful selection of an assessment tool sensitive enough to detect subtle
differences in neurodevelopment in a largely healthy cohort of children
Methodological Issues pertaining to the use of an assessment tool in a multi-cultural sample
should be addressed
Issues pertaining to the acquisition of language skills in children with different
native languages should be addressed




Training of field workers in the administration of the selected tool should be easy
and specialist training in pediatrics, psychology or neuroscience should not be a
pre-requisite
The assessments should be relatively inexpensive to administer
The assessments should be rapid to administer to prevent over burdening field
workers and spurious low scores due to child fatigue
doi:10.1371/journal.pone.0113360.t004
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Phase 1 involved a search of online databases (PubMed, PsycINFO and
Embase) using search terms for cognition, language, motor skills and behavior.
These are listed in Table S1 in File S1.
During Phase 2, the Infant Development Group contacted a number of child
development experts and authors of child psychometric measures from
Bangladesh, Brazil, India, Italy, Kenya, the Netherlands, UK and USA. The experts
were asked to list the available measures they were familiar with to assess
cognition, language, motor skills and behavior at 24 months.
Phases 1 and 2 (Figure S1 in File S1) resulted in a list of 47 tools (Table S2 in
File S1). Their purpose, the age ranges at which they may be used, the domains
assessed and the languages the tools are currently available in are summarized in
Table S2 in File S1. The Infant Development Group critically analyzed these tools
against the criteria listed in Table 3. Thirteen fulfilled some of the Project’s
criteria. Information on the characteristics, purpose, and strengths and weaknesses
(in to the context of the INTERGROWTH-21st Project) of each tool is presented
in Table S3 in File S1.
The 13 tools were critically analyzed against the Project’s criteria by a scientific
advisory panel of independent international experts in the fields of neurodeve-
lopment, pediatric neurology, child psychiatry, child psychology, vision,
neuroscience, ophthalmology, sleep research, perinatal medicine and epidemiol-
ogy at a meeting organized by the Infant Development Group.
Results of Approach 1: The findings of Phases 1 and 2, as reviewed by the
scientific advisory panel, resulted in four key conclusions. First, the panel
acknowledged that no one tool fulfilled all the Project’s criteria. Second, the panel
found 5 of the 13 tools to individually fulfill most of the Project’s criteria and
recommended the use of these tools in their most sensitive and reliable domains
of neurodevelopment (Table 5). These were the Bayley Scales of Infant
Development – Third Edition (BSID) [19, 20], the Rapid Neurodevelopment
Assessment (RNDA) [21], the Malawi Development Assessment Tool (MDAT)
[22], the Griffiths Mental Development Scale [23, 24] and the Child Behaviour
Checklist (CBCL) [25, 26]. Third, the panel recommended that while it is almost
impossible for any psychometric instrument measuring ECD to be free from
cultural biases, it is possible to undertake a decentering approach by selecting
items that are suitable for middle- and upper-class families in high-, middle- and
low-income contexts [27]. In this approach, no single cultural group provides the
initial items sets. Instead the test development process sets out to select items that
are equally familiar to the different target groups and excludes any materials or
content that seems unfamiliar to any of the target groups. The rationale for this
approach was that in the current global situation, children from most middle- and
upper-class families across settings are exposed to a set of similar resources (such
as cups, spoons, dolls, crayons, shoes, stacking blocks) and therefore it is possible
to pool this common set of exposures to select a set of items that most middle-
and upper-class children across high-, middle- and low-income settings can
perform. Finally, the panel suggested a package-based approach combining the
use of psychometric tools with neurophysiological measures. The panel
The INTERGROWTH-21st Project Neurodevelopment Package
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recommended that the methodology, scope and sensitivity of such a package must
be tailored to the needs of the INTERGROWTH-21st Project.
Approach 2: A multi-dimensional package for the assessment of
neurodevelopment at 24 months
Based on the recommendations of the scientific advisory panel, the Infant
Development Group undertook a structured, package-based approach to
construct a neurodevelopment assessment protocol customized to the needs of the
Project and the characteristics of the study population. The design of the Package
Table 5. Neurodevelopment tools selected following review of candidate tools by scientific advisory panel.
Tool Positive Features Negative Features
BSID-III N Considered to be the gold standard for psychometric evaluation of
children ,3 years of age
N Long administration time (60-90 minutes)
N Specialist training required
N Sensitive diagnostic instrument to detect subtle differences in
neurodevelopment in a normal, healthy cohort
N Expensive
N Concern about the cultural bias of items and norms
N Good predictive and discriminant validity
24 month version of
the RNDA
N Quick and easy to administer N Information on sensitivity, specificity and positive
predictive value at 24 months not available
N Yield continuous scores
N Used in LMIC samples N Not validated in HIC settings
N Administration does not require specialist training N Not all items are free from cultural biases
N Characterizes neurodevelopmental outcomes across a spectrum
ranging from mild to severe delay
N Very few items in each domain
N No evidence to indicate the measure would be suitable
for use within an optimally healthy population
MDAT N Quick and easy to administer N Not validated in HIC settings
N Yields continuous scores N Not all items are free from cultural biases
N Used in LMIC samples N No evidence to indicate the measure would be suitable
for use within an optimally healthy population
N Administration does not require specialist training
N Strong items in the language domain
Griffiths Scales N Sensitive diagnostic instrument to detect subtle differences in
neurodevelopment in a normal, healthy cohort
N Long administration time (60–90 minutes)
N Validated in a number of international settings N Specialist training required
N Strong items in the gross motor domain N Expensive
N Not all items are free from cultural biases
Pre-school version of
the CBCL
N Sensitive diagnostic tool to detect behavioral, emotional and
attention problems
N Subject to reporter/recall bias
N Validated in international settings and available in a large number of
languages
N Does not assess cognitive, motor and language skills
N Has a sleep and stress problems scale N Some items may not be free from cultural biases
N Short administration time (approximately 15 minutes)
BSID 5 Bayley Scales of Infant Development III edition, RNDA 5 Rapid Neurodevelopment Assessment, MDAT 5 Malawi Development Assessment Tool,
Griffiths Scales 5 The Griffiths Mental Development Scale, CBCL 5 Child Behavior Checklist
doi:10.1371/journal.pone.0113360.t005
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was also guided by its potential for use as a population-based screening
instrument for ECD in the context of LMICs and HICs. The process leading to the
development of the Package was undertaken in five stages: (1) the neurodeve-
lopment outcomes we wished to assess were grouped into similar domains; (2) a
set of domain-specific criteria to be fulfilled by each neurodevelopment measure
were developed; (3) the candidate measures that fulfilled the criteria for each
domain were listed, based on the results of the systematic review, and discussions
with experts and the scientific advisory panel; (4) the list of domain-specific,
candidate measures was critically analyzed against the criteria for each domain
and the most appropriate measure for each domain was selected by the scientific
advisory panel and the Infant Development Group; and (5) the various measures
were incorporated into a singular assessment package with domain-specific
protocols.
Results of Approach 2: 1) Categorization of desired neurodevelopment
outcomes into domains
Ten neurodevelopment outcomes were listed as priorities for the Project:
cognition, language, gross motor skills, fine motor skills, behavior, attention,
emotional reactivity, overall visual function, cortical auditory processing, and
sleep. The rationale for the selection of these outcomes was each outcome has
been previously found to have long-term predictive ability [7, 8, 28–30] and well-
established psychometric, neurophysiological and/or clinical tests are available to
measure them. The 10 outcomes were grouped into four domains based upon the
balance between the technical, conceptual and logistical feasibility of assessing
each domain on an international sample in accordance with the criteria and
requirements of the INTERGROWTH-21st Project. The domains are:
1. Vision: Visual acuity and contrast sensitivity
2. Neuropsychological function: Cognition, language, gross motor skills, fine
motor skills, behavior, attention, emotional reactivity
3. Auditory function
4. Sleep
Language was included in domain 2 (neuropsychological function) rather than
domain 3 (auditory function) in keeping with the contextual framework of the
candidate measures. Furthermore, the expert panel felt it would be logistically
more feasible to administer items on receptive and expressive language together
with the cognitive, motor and behavior items and that this practice would
contribute to a greater fluidity and continuity of the assessment for both the child
and the assessor.
2) Domain-specific test selection criteria
A set of criteria to be fulfilled by a measure (psychometric, neurophysiological,
clinical or a combination of these) for each domain was compiled by the Infant
Development Group and approved by the scientific advisory panel. The test
selection criteria for each domain are conceptually similar to the overall Project
criteria depicted in Table 3. These are listed in detail in Tables S5–S8 in File S1.
3) Candidate measures for each domain
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3.1) Vision
Conventional measures of vision in adults, such as the Snellen chart, require
levels of comprehension, concentration and verbal skills that a young child may
not possess. Therefore, in addition to the criteria listed in Table S4 in File S1,
attention was paid to the candidate measures below being suitable for young
children and free from biases introduced due to potential cognitive and language
difficulties. These candidate measures, grouped as tests of visual acuity and
contrast sensitivity, are listed below:
I. Measures of Visual Acuity
Tests of visual acuity measure the child’s ability to discern objects at a given
distance according to a fixed standard. These include:
(a) Tests using subjective/behavioral methods based on the forced choice
preferential looking (FPL) method, conceived by David Teller [31]. In this
method, the observer presents the child with a display, half of which is plain
while the other half contains a pattern. The child tends to look at the pattern
if he/she can resolve it. This technique becomes a ‘‘forced choice’’ when the
observer has to decide, based on the child’s head and eye movements, where
the stimulus is located [32]. The threshold is defined as when the child makes
a ‘‘clear’’ look. These methods consist of measures of resolution acuity (Teller
acuity test [31], Keeler acuity test [33], Cardiff test [34], and grating and
operant preferential looking techniques [35]) and measures of recognition
acuity (Kay pictures, LEA symbols, Cambridge crowding cards, Landolt C-s
and crowded Landolt C-s) [36, 37].
(b) Experiments using objective methods involving the measurement of pattern
steady-state visual evoked potentials (VEP) and variations of the same (for
example, sweep VEP) using electroencephalographic techniques [36].
I. Measures of Contrast Sensitivity
Tests of contrast sensitivity assess the minimum contrast necessary for a subject
to detect sine wave gratings of different spatial frequencies [35]. The measurement
of contrast sensitivity is thought to reflect the integrity of the entire visual
pathway, and is considered the ‘‘single most complete measure of human spatial
vision’’ [37]. The measures include:
(a) Tests using subjective/behavioral methods (Cardiff tests, Alley-running 2AFT
staircase, Vistech charts and Pelli-Robinson Charts) [37].
(b) Tests using objective methods, namely those measuring VEPs [36].
3.2) Neuropsychological function:
The findings of approach 1 were applied to the selection of candidate tools for
the assessment of cognition, language, gross motor skills, fine motor skills,
behavior, attention and emotional reactivity. Approach 1 has been described in
detail above and the results of this process are enumerated in Tables S3 and S4 in
File S1, and Table 5. Of the 47 measures initially identified, 13 were found to
fulfill some of the Project’s criteria, the top 5 of which were selected as candidate
I.
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measures for use in the INTERGROWTH-21st Project. These were the BSID
[19, 20], the RNDA [21], the MDAT [22], the Griffiths scale [23, 24] and the
CBCL [25] and were selected on the basis of their functionality to sensitively assess
cognition, language, gross motor skills, fine motor skills and behavior at 24
months of age.
3.3) Auditory function:
There were five candidate tests for the assessment of auditory function as per
the domain-specific criteria listed in Table S6 in File S1. These were audiometry,
acoustic reflex threshold measurement, otoacoustic emission measurement,
communication inventories and the measurement of evoked response potentials
(ERPs) to auditory stimuli [38].
3.4) Sleep:
The candidate tools for sleep were classified by recording technique, as follows:
I. Caregiver reports: These include sleep diaries and questionnaires. In the
former, the caregiver maintains a diary recording of the child’s activities, sleep
and wake times and napping [39]. Sleep questionnaires assess the quality and
frequency of the child’s sleep [39, 40].
II. Neurophysiological techniques: These include polysomnography (PSG) and
actigraphy. PSG is the comprehensive measurement of the various biophysical
changes that occur during sleep and involves the simultaneous recording of
brain and heart signals, eye movements and muscle activity from multiple
channels placed on the participant’s head, face, limbs and chest [41]. The test
is conventionally conducted in a sleep laboratory. Actigraphs are watch-like
devices placed on the wrist or ankle to record movement [42]. The data are
analyzed for periods of activity and inactivity to estimate sleep patterns and
circadian rhythms [43].
4) Selection of test for each domain
4.1) Vision
The candidate tools for visual acuity and contrast sensitivity were assessed
according to the specific criteria listed in4 in File S1. FPL techniques, particularly
Cardiff Tests, Teller cards and Keeler cards, met the Project’s criteria better than
objective (neurophysiological) techniques (Table 6). A further analysis of the
Cardiff, Teller and Keeler tests, presented in Table 7, showed the Cardiff tests to
be the most appropriate for the purposes of the INTERGROWTH-21st Project
because (1) they measure both visual acuity and contrast sensitivity and (2) the
images are more attention-grabbing and engaging for toddlers than the black and
white pictures of the Teller/Keeler cards [33, 34, 44]. The Cardiff acuity and
contrast sensitivity tests [34, 45] were, therefore, selected as the vision assessment
of choice for the neurodevelopment package of the INTERGROWTH-21st Project.
4.2) Neuropsychological function
The analysis of the 5 candidate measures; namely the BSID [19], the RNDA
[21], the MDAT [22], the Griffiths Scale [23, 24] and the CBCL [25]; against the
domain specific criteria for the INTERGROWTH-21st Project (Table S5 in File S1)
is presented in Table 8. As none of the measures were found to meet all the
The INTERGROWTH-21st Project Neurodevelopment Package
PLOS ONE | DOI:10.1371/journal.pone.0113360 November 25, 2014 14 / 34
Project’s criteria, the scientific advisory panel and the Infant Development Group
concluded that the Project should use a combination of the candidate tools, by
integrating the strengths of some measures to complement the weaknesses of
others. A 53-item tool, the INTERGROWTH-21st Neurodevelopment Assessment
(INTER-NDA; Table 9), was designed by including 30 cognitive, language and
motor items; 6 behavioral items and 17 items measuring attention and emotional
reactivity. These items were selected by international experts in child development
who had extensive experience with the candidate measures and with the
development of psychometric tools. The rationale for the selection of each
individual item was based on the experts’ agreement on (i) its suitability for the
22–26 month age group; (ii) its appropriateness for use in international
populations using the decentering approach described earlier; (iii) its ability to be
administered reliably and (iv) its ability to be adapted across cultural contexts.
The administration and scoring of the items was adapted for the purpose of the
Project and care was taken to ensure conceptual equivalence was maintained
between the items of the INTER-NDA and those of the 5 candidate measures of
neuropsychological function. A 5-point Likert scale was selected to objectively
record the child’s performance on each item with a view to characteristic levels of
achievement for each item across a spectrum (rather than a binary pass/fail
outcome measure). As raw scores for the candidate measures were not freely
available it was not possible to select items following a statistical analysis of item
Table 6. Analysis of candidate vision tests against selection criteria.
Selection Criteria Tests of vision
Essential Criteria: Forced preferential looking
techniques
Neurophysiological techniques
1. The test must be suitable to assess vision in 2 year olds. + +
2. The test must assess the entire visual pathway and not merely specific
components of the ophthalmic apparatus.
+ +
3. The test must be sensitive enough to detect subtle differences in vision
in a healthy cohort of children.
+ +
4. The test must yield an objective score of vision. + +
5. The test must possess established validity + +
6. The measurement of vision must not be affected by disturbances in
language development, cognition, and/or hearing.
+ +
7. The test must be suitable for use in LMICs and in low-resource settings, and
should not contain items that are culture or language specific.
+ +
8. The duration of assessment for each individual child must not exceed
10 minutes.
+ -
9. It must be easy to train local field workers to administer the test and




1. The test should require minimal infrastructure and any equipment to
administer the test must not be expensive.
+ -
2. The test should assess more than one aspect of vision. + +
doi:10.1371/journal.pone.0113360.t006
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weights. The assessment of behavior encompasses the assessor’s observation of
child’s overall behavior during the assessment, and does not include reports on
specific constructs of behavior such as temperament and empathy. The operation
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manual and training materials of the INTER-NDA are freely available at www.
intergrowth21.org.uk/protocol.aspx?lang51.
4.3) Auditory function
The candidate tools for auditory function were analyzed according to the
domain specific criteria (Table 10, Table S6 in File S1). Audiometry and the
measurement of auditory ERPs were the only tests found to: (i) be sensitive
enough to detect subtle differences in auditory function in a cohort of healthy
children and (ii) assess the entire auditory pathway [46]. Audiometry was,
however, found to be difficult to perform reliably in children less than three years
of age [46, 47]. Although the measurement of acoustic reflex thresholds and
otoacoustic emissions detect the most common causes of hearing impairment in
children they solely assess middle ear function, and not the entire auditory
pathway [48]. In addition, these tests require a probe to be placed in the child’s
ear for up to 3 minutes, which would pose considerable difficulties with
compliance in the field [48].
The measurement of auditory ERPs using the novelty oddball ERP task [49]
was the method of choice for the Project. This technique has been validated in
young children and tests their ability to discriminate novel stimuli embedded in a
Table 8. Analysis of candidate cognitive, language, motor, behavior and attention tests against selection criteria.
Selection Criteria Neurodevelopment Assessments/Questionnaires
Essential Criteria: BSID RNDA MDAT Griffiths CBCL
1. The test must be suitable to assess neurodevelopment in 2 year olds. + + + + +
2. The test must assess the following aspects of neurodevelopment:
(a) cognition + + + + -
(b) language + + + + -
(c) motor skills + + + + -
(d) behavior + + + + +
(e) attention - - - - +
(f) emotional reactivity. - - - - +
3. The test must be sensitive enough to detect subtle differences in
neurodevelopment in a healthy cohort of children.
+ - - - +
4. The test must characterize outcomes across a spectrum. + + + + +
5. The test must possess established reliability and validity in international
settings.
+ + + + +
6. The test must be free from culture-specific items and suitable for use in
both HICs and LMICs.
- + - - -
7. The test must be based upon objective reporting and not subjective
judgment of the child’s performance.
+/- - +/- +/- -
8. The duration of assessment for each individual child must not exceed
30 minutes.
- + - - -
Desirable Criteria:
1. The test should employ a combination of methodologies including but not
limited to direct tests, observation and caregiver reports.
+ + + - -
2. The test should require minimal infrastructure and any equipment to
administer the test must not be expensive.
- + + - +
doi:10.1371/journal.pone.0113360.t008
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Table 9. Constituent items and scoring sheet of the INTERGROWTH-21st Neurodevelopment Assessment.
The INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA)
No. Item Observed performance
1 Builds a tower of 5 cubes
(trials 53, demonstration 53)
5 cubes 3–4 cubes 2 cubes No attempt
2 Names 4 colors when asked to
do so (trials 50)
Names 4 colors Names 3 colors Names 1 or 2 colors Does not name any
color
3 Matches 3 cubes of same
colors when requested to do
so (trials 51, demonstration
51 of one color)
Matches 3 colors Matches 2 colors Matches 1 color Does not match any
color
4 Hands the examiner one cube
when asked to do so (Examiner
says ‘‘Please give me one
cube’’ & keeps palm open for 5
seconds after child has handed
over 1 cube; trials 51)
Hands only one block
within 5 seconds
Hands only one block in
more than 5 seconds
Hands two or more blocks Does not hand any
block/No attempt
5 Puts the spoon in the cup when
asked to do so (trials 55)
Puts the spoon in cup in
#3 trials
Puts the spoon in cup in
#3 trials in 4–5 trials
Takes the spoon or the
cup but does not complete
action
No attempt
6 Matches shapes on board
(trials 55, demonstration 51
if 1st trial unsuccessful)
All shapes in #3 trials All shapes with repeated
demonstration i.e. 4–5
trials
One or two shapes 4–5
trials
No attempt
7 Matches shapes on rotated
board (trials 55, demonstra-
tion51 if 1st trial unsuccessful)
All shapes in #3 trials All shapes with repeated
demonstration i.e. 4–5
trials
One or two shapes 4–5
trials
No attempt
8 Points correctly when asked
‘‘Where is the door/entrance to
the room?’’ (trials 55)
Identifies door correctly in
#3 trials
Identifies door correctly in
4–5 trials
Attempts, but does not
identify door
No attempt
9 Puts a raisin precisely inside a
small opening in a bottle (trials
51, demonstration 51; test
both hands)
Precise release of raisin
into bottle with each hand
Clumsy release, raisin
falls out of bottle with one
or more hand
Attempts but unsuccessful
release with one or more
hand
No attempt
10 Drinks water from cup/sippy
cup when placed in front of
child (trials 51, maternal report
if sippy cup unavailable)
Drinks in a well-coordi-
nated manner without
spilling
Drinks clumsily & spills Attempts but unsuccessful No attempt
11 Looks towards an object
located across the room when
pointed at by the examiner
(trials 55)
Looks or points at object
in #3 trials
Looks or points at object
in 4–5 trials
Looks at the wrong object,
or attempts but cannot
identify object
No attempt
12 Pretends to drink from the cup
when a cup is placed in front
of him/her (trials 51, demon-
stration 51)
Spontaneous After 1 demonstration Partial attempt after 1
demonstration
No attempt
13 Able to make a cup of tea with
the toy tea set when requested
by examiner (Examiner says
‘‘Can you make a cup of tea?’’)
(trials 52, demonstration 51 if
1st trial unsuccessful)
Spontaneous After 1 demonstration Partial attempt No attempt
14 Feeds doll when requested to
(Examiner says ‘‘Can you give
the dolly some tea?’’) (trials 52,
demonstration 51 if 1st
trial unsuccessful)
Spontaneous After 1 demonstration Partial attempt after 1
demonstration
No attempt
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Table 9. Cont.
The INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA)
No. Item Observed performance
15 Imitates straight scribble
(trials 55, demonstration 55)
#3 trials 4–5 trials; with difficulty Attempts (hold crayon) Cannot hold crayon
16 Identifies glitter bracelet
under correct washcloth
(trials 55, test both sides)
Finds bracelet correctly
in #2 trails on both sides
Find bracelet correctly
in 3 trials or on one
side only
Find bracelet correctly in
4–5 trials or on one side
only
Does not find bracelet or
no attempt
17 Correctly identifies object
groups using plurals
Uses 5 plurals Uses 3–4 plurals Identifies 1–2 plurals Does not use any plur-
als
18 Asks for toilet by gesture or
verbally (maternal report)
Always Occasionally Partial (only for bowel
movement)
Never
19 Runs (maternal report) Runs steadily Attempts Walks only Walks with support
20 Throws a ball very near
(trials 51, demonstration 51,
test both sides)
Good release Unsteady release Attempts No attempt
21 Kicks ball (maternal report) Kicks ball with flexed Attempts Walks only No attempt
22 Climbs upstairs holding rail,
2 feet/stair or in adult fashion
(maternal report)
Climbs stairs alone hold-
ing rail
Unsteady Needs help No attempt
23 Uses 2–4 syllable babble
such as dada, mama but
not specifically to anything
or any person
Spontaneously Mimics 1 syllable babble e.g. ba,
ma, da
None
24 Use two words together Yes, appropriate use Yes, in appropriate use One word No attempt
25 Indicates by gesture to say
no (maternal report if not
observed during
assessment)
Indicates in #3 trials Indicates in 4–5 trials Attempts, but incomplete
indication
No attempt
26 Use of a pronoun e.g. me,
my, she, he, it, I
Correct use Incorrect use No use No use
27 How many words does the child
use during the assessment
other than mama/dada
>8 words 6–7 words 4–5 words #3 words
28 How many sentences of 3
words or more does the
child use during the
assessment?
>2 1 Only two – one word
utterances
None
29 In how many instances
does the child follow on
a topic of conversation
providing new information?






Uses any number of
words, provides incorrect
information
Does not follow up on
conversations
30 Combines word and
gesture when asked
(trials 51, do not
demonstrate)








What is the child’s native (first)
language?
What is the language in which the
assessment is being conducted?
Does the child speak/understand any
languages other than his/her native
(first) language?
How often were the following behaviors in the child during the assessment?
31 Positive Affect Never or rarely Some of the time Most of the time
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train of frequent stimuli [49]. It involves the presentation of frequent, infrequent
and novel auditory stimuli, and the measurement of the amplitude and latencies
of distinct EEG waveforms to each stimulus. The waveforms of interest include
the P1 (a positive peak around 100 ms after stimulus onset), the N2 (a negative
peak around 200 ms) and the P3a (a positive peak around 250–350 ms).
However, measuring auditory ERPs involves recording EEG signals from the
child’s scalp. This is complicated because it requires specialist training,
sophisticated equipment, long set-up times and possibly sedation of the child
[46]. The Infant Development Group had specific concerns about the co-
operation of children, the consent of mothers and the ease of implementation of
this technique in the field, especially in low resource settings, with conventional
Table 9. Cont.
The INTERGROWTH-21st Neurodevelopment Assessment (INTER-NDA)
No. Item Observed performance
32 Exploration Never or rarely Some of the time Most of the time
33 Ease of engagement Never or rarely Some of the time Most of the time
34 Cooperativeness Never or rarely Some of the time Most of the time
35 Adaptability to change Never or rarely Some of the time Most of the time
36 Distractibility Never or rarely Some of the time Most of the time
37 Negative affect Never or rarely Some of the time Most of the time
Caregiver Reported Child Behaviour Questionnaire
Instructions to caregiver: Please fill in this form to reflect your view of your child’s behavior, even if others do not agree
38 Likes playing with other children Not true Sometimes true Often true
39 Can’t concentrate, can’t pay
attention for long
Not true Sometimes true Often true
40 Can’t sit still, restless or
hyperactive
Not true Sometimes true Often true
41 Disturbed by any change in
routine
Not true Sometimes true Often true
42 Nervous movements or twitching Not true Sometimes true Often true
43 Shows panic for no good reason Not true Sometimes true Often true
44 Poorly coordinated or clumsy Not true Sometimes true Often true
45 Quickly shifts from one activity
to another
Not true Sometimes true Often true
46 Rapid shifts between sadness
and excitement
Not true Sometimes true Often true
47 Sudden changes in mood or
feelings
Not true Sometimes true Often true
48 Sulks a lot Not true Sometimes true Often true
49 Upset by new people or situations Not true Sometimes true Often true
50 Wanders away Not true Sometimes true Often true
51 Whining Not true Sometimes true Often true
52 Worries Not true Sometimes true Often true
53 Responds well to affection Not true Sometimes true Often true
END
doi:10.1371/journal.pone.0113360.t009
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Table 10. Analysis of candidate auditory function tests against selection criteria.
Selection Criteria Measures of auditory function




Communication Inventories Auditory ERPs
1. The test must be
suitable for assessing
auditory function in
children at 2 years
of age.
- + + + +
2. The test must assess
the entire auditory




+ - - - +
3. The test must be
sensitive enough to
detect subtle differences
in auditory function in a
healthy cohort of children.
+ + + - +
4. The technique must
possess established
validity and be a
well-established measure
of auditory function in
children.
+ + + + +
5. The measurement of
auditory function must
not be affected by
simultaneous disturbances
in cognition, and/or vision.
+ + + - +
6. The technique must be
suitable for use in LMICs
and in low-resource
settings, and should not
contain items that are
culture or language
specific.
+ + + - +
7. The duration of
assessment for each
individual child should
not exceed 20 minutes.
- + + + +
8. It must be easy to
train local field workers
to administer the test





- - - + -
Desirable Criteria:
1. Any equipment to
administer the technique
must not be expensive
or difficult to use.
- - - + -
2. The technique should
yield objective measures
of amplitude and latency
of responses.
+ + - - +
doi:10.1371/journal.pone.0113360.t010
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EEG apparatus and methods. To meet these challenges, the Group designed a
novel method of measuring auditory ERPs in children employing a ‘strap and
click’ design using a wireless EEG cap and dry electrodes [50].
4.4) Sleep
The candidate tools to measure sleep in children were analyzed according to
domain specific criteria (Table S7 in File S1, Table 11). Actigraphy was found to
be the only method of assessment that was: (i) of sufficient sensitivity to measure
subtle differences in sleep in a healthy cohort of children, (ii) objective, (iii)
minimally disruptive to the daily routine of the mother and child, and (iv) able to
record sleep patterns and daytime physical activity in a natural, home based
setting [42, 43]. However, leading actigraphy and sleep experts on the scientific
advisory panel felt that actigraphy alone may not adequately capture the child’s
sleeping pattern as the information collected is limited by the number of days that
the child wears the actiwatch. It was therefore decided that the use of a well-
established maternally reported sleep questionnaire, such as the Brief Infant Sleep
Questionnaire [51], in conjunction with actigraphy may be a more reliable
Table 11. Analysis of candidate sleep measures against selection criteria.
Selection Criteria Measures of sleep & circadian rhythm
Essential Criteria: Caregiver reports Neurophysiological methods
Sleep Diary Sleep Questionnaire Polysomno-graphy Actigraphy
1. The test must be suitable for assessing sleep in
children at 2 years of age.
+ + + +
2. The test must be sensitive enough to detect subtle
differences in sleep in a healthy cohort of children.
+/2 +/2 + +
3. The test must possess established validity and be a
well-established measure of sleep in children.
+ + + +
4. The test must be an objective measure of sleep in
children.
- - + +
5. The test must be as non-disruptive to daily life as
possible for both the child and the caregivers, and should
not require prolonged periods of recording in laboratories.
+ + - +
6. The test must measure sleep in a natural, home based
setting.
+/2 +/2 - +
7. The test must be suitable for use in LMICs as well as
HICs.
+/2 + - +
8. t must be easy to train local field workers to administer
the tool and no specialist training in pediatrics, child
psychiatry, neuroscience or related disciplines must be
necessary.
+ + - +
Desirable Criteria:
1. Any equipment to administer the technique should not
be expensive.
+ + - +/2
2. The technique should yield information on a range of
sleep characteristics including but not limited to sleep
efficiency, total duration of sleep and nighttime awakenings.
- - + +
3. The technique should yield information about the extent
of the child’s motor activity during the day.
- - - +
doi:10.1371/journal.pone.0113360.t011
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method of assessing sleep and daytime activity patterns in children than either
alone.
Results and Discussion
The INTERGROWTH-21st Neurodevelopment Package
The INTERGROWTH-21st Neurodevelopment Package describes a multi-
dimensional, mixed-methodology approach to assessing neurodevelopment in
preschoolers. The Package is the result of the combined efforts of the Infant
Development Group and the scientific advisory panel to develop a holistic,
scalable instrument to measure ECD that is easy to implement across different
contexts and settings for population-based research and screening purposes. The
Package, in its entirety, meets all the Project’s requirements listed in Table 3,
while each individual component of the Package fulfills domain specific criteria
listed in Tables 6, 8, 10 and 11.
Characteristics of the Package
The package consists of four constituent assessments (Fig. 3). These include a test
of vision; a measure of cognition, language, motor skills, behavior, attention and
emotional reactivity; a test of cortical auditory processing and a measure of sleep
patterns and daytime physical activity. The package takes between 35 and
45 minutes to administer and consists of a combination of psychological,
neurophysiological and clinical tests, and caregiver reports.
Key Features
The important features of the Package are that it:
1. Is a multi-dimensional assessment of neurodevelopment in preschoolers
using a mixed methodology approach
2. Was developed for, and is currently in use in, middle- and upper-class
children across low-, middle- and high- income settings
3. Can be delivered in the field by non-specialist staff with minimal training
4. Yields objective, rather than subjective, information about a child’s
performance
5. Incorporates the assessment of entire vision and auditory pathways rather
than individual anatomical/physiological components of these pathways.
Implementation of the INTERGROWTH-21st Neurodevelopment
Package
Automation
A number of components of the Package were automated to facilitate rapid
administration, real-time data upload and integrated quality checks in the data
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collection system. A tablet-based data collection application, the NeuroApp, was
designed for this purpose. The NeuroApp is an intuitive user interface with
integrated operation manuals. It consists of: (a) a biography page, (b) a
neurodevelopment home page providing access to the tests for the four
constituent domains, and (c) vision, INTER-NDA, cortical auditory processing,
and sleep pages on which the child’s performance on each individual test are
recorded. Integrated quality checks ensure that no more than one option is
selected for each item and any items with missing data are flagged before the data
upload stage.
To ensure that non-specialist research staff can carry out the cortical auditory
processing experiment, a ‘strap-and-click’ design was developed. This method
involved hardware and software customization of the EEG system (Enobio,
Neuroelectrics, Barcelona) to automate the presentation of the auditory stimuli
and the recording, termination and upload of the corresponding electrophysio-
logical data following a simple initial set-up.
The Package’s tri-axial actigraph of choice, marketed as the Motionwatch 8
[52], is reliable under harsh climate conditions, waterproof, easy to set up and use,
and has a relatively long battery life. It does not require calibration and data are
easy to download onto a computer using the Motionware software. The data are
uploaded onto a dedicated sleep section on the Project’s centralized database
using a standard file transfer protocol.
In order to ensure that non-specialist research staff involved in the study are
capable of conducting psychological, neurophysiological and clinical tests to the
same degree of proficiency as specialist research staff a comparison of the data
quality obtained between the two will be carried out following the conclusion of
Figure 3. Components of the INTERGROWTH-21st Neurodevelopment Package.
doi:10.1371/journal.pone.0113360.g003
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data collection. Although there is considerable doubt among the scientific
community about the validity of neurodevelopment assessments being carried out
by non-specialist research staff with minimal training, the INTERGROWTH-21st
Project offers the opportunity to test the hypothesis that with targeted training,
user-friendly apparatus and a high degree of automation (including integrated
quality checks), non-specialist field workers may be able to achieve levels of
proficiency at power with specialist research staff. We believe this would be an
important step ahead in the field where the lack of trained personnel is often the
rate-limiting step in the scalability of ECD screening packages, especially in
LMICs.
Database organization
Neurodevelopment data from all study sites are stored securely in a dedicated
neurodevelopment section on the Project’s centralized, cloud-based database.
Neuropsychological and vision data (in.txt format) are uploaded instantaneously
from the NeuroApp following the completion of an assessment. EEG data (in.zip,
info and.easy formats) are uploaded automatically from the EEG software.
Actigraphy data (in.awd format) are uploaded through a standard file transfer
protocol. The database for the Project was designed, and is maintained, by
MedSciNet, (Stockholm, Sweden) and managed by local and coordinating unit
data managers with varying levels of access and administrative rights. Information
on the organization of the database, data access and security is available elsewhere
[53].
Training
The Infant Development Group devised the training strategy for the Package by
taking into consideration the requirements of each site. The training session,
which lasts 3K days, is conducted at each site by the coordinator of the Infant
Development Group. Day 1 consists of 6 sessions where trainees are introduced
to, and trained in, the various theoretical and practical aspects of Package using a
combination of direct instruction, small group interaction, role-play and
problem-based learning. Day 2 consists of 9 sessions – 6 refresher sessions, a
demonstration and 2 live sessions. Day 3 consists of 3–4 live sessions and a video
based standardization session to assess inter-rater and test-re test reliability. The
half-day consists of a further live session, written test and discussion about the
standardization session. At the end of every live assessment, the trainees are
encouraged to discuss the assessment with the trainer and give feedback. Specific
attention is paid to problem areas and site-specific cultural issues at this point.
The rationale for conducting on-site, rather than centralized, training sessions is
to enable the trainer to help the teams with site-specific issues and to test the
apparatus. It also provides an opportunity for the trainer to liaise with the IT and
data experts at the sites and to troubleshoot initial problems.
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Cultural customization
At each training session, the site team together with the coordinator of the Infant
Development Group compiles a list of item-based culture-specific issues for the
site and discusses solutions to address these problems. The issues largely concern
the amendment of phrases during the administration of the INTER-NDA to more
culturally-appropriate conceptual equivalents (for example, in item 30 on
combining a word and gesture, it was found that certain phrases such as ‘show me
Gota’ in Kenya, and ‘do Namaste’ in India, worked better than English versions
such as ‘blow a kiss’ or ‘wave bye’). For maternally reported items on attention
and emotional reactivity, local language versions (Brazilian Portuguese, Hindi,
Italian, Kiswahili and Marathi) from validated CBCL translations were made
available to the site staff.
Reliability Analysis and Comparison with Other
Neurodevelopment Scales
The inter-rater and test-re test reliability of the INTER-NDA was determined
across 21 assessors in Brazil, India, Italy, Kenya and the UK. This was carried out
using video recordings of INTER-NDA assessments on four children performed
by an expert assessor (MF). All assessors were instructed to simultaneously score
each child according to a standardized reliability protocol. Cohen’s kappa
coefficients of reliability were calculated. These were found to be substantial for
both inter-rater reliability (k50.70, 95% CI: 0.47–0.88) and test-re test reliability
(k50.79, 95%CI: 0.48–0.96).
A study to evaluate the agreement between the INTER-NDA and the BSID-III is
currently underway at our Oxford site. The results of this analysis will be
published separately.
Progress to date
The INTERGROWTH-21st Project teams in Brazil, Kenya, India, Italy and the UK
were trained between November 2012 and September 2013. Implementation of
the Package commenced in the UK in February 2013, followed by Kenya, India
and Italy in April 2013 and Brazil in November 2013. To date, 829 children in
these sites have been assessed.
The Package takes between 35 and 45 minutes to administer in the field. The
duration of each component of the Package is as follows: vision, 5 minutes;
INTER-NDA, 15–20 minutes; cortical auditory processing, 12 minutes, and sleep,
3–5 minutes. The mean administration times in each site, rounded to the nearest
5 minutes, are as follows, – Brazil: 40 minutes, India: 45 minutes, Italy:
45 minutes, Kenya: 40 minutes and the UK: 35 minutes.
The Package was found to be easy to administer in all sites. Technical
difficulties including electricity failures during ERP recordings and Internet
connectivity problems occurred to a small extent in all sites. The HIC sites
witnessed greater difficulty in persuading children to keep the wireless EEG cap on
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for the entire duration of 10 minutes as compared to the LMIC sites. The return
of the actiwatch to the study center by post proved to be difficult in the Indian,
Italian and Kenyan sites and alternative methods of delivery, such as courier
services, were therefore organized.
Discussion
The INTERGROWTH-21st Neurodevelopment Package describes, to the best of
our knowledge, the first multi-dimensional instrument for early child develop-
ment, for both research and screening purposes, that is designed to be carried out
by non-specialist assessors and that has been developed for use in children from
middle- and upper class families across low-, middle- and high-income settings.
The Package assesses visual acuity and contrast sensitivity (with the Cardiff tests);
cognition, language, motor skills, behavior, attention and emotional reactivity
(the INTER-NDA); cortical auditory processing (measuring auditory ERPs to a
novelty oddball paradigm) and sleep-wake patterns and daytime physical
actigraphy (actigraphy and maternal reports). The Package is in use in the
INTERGROWTH-21st study sites in Asia, Africa, Europe and South America
where more than 700 children have been assessed. The operation manuals and
protocols are freely available at www.intergrowth21.org.uk/protocol.aspx?lang51.
This paper describes the conceptual and methodological challenges encountered
during the selection of multi-dimensional ECD measures and outlines the
methodological process of systematic evaluation and tool selection undertaken by
the INTERGROWTH-21st Project towards the development of the Package. The
paper also presents an overview of, to our knowledge, the most well-established
psychometric measures of ECD for preschoolers. We believe that both the
description of the systematic approach leading to the development of the Package,
and the findings of the overview of psychometric tools to assess ECD in
preschoolers, may be of use to researchers, policy makers and organizations
involved in ECD research and surveillance at local, national and global levels when
selecting and/or designing multi-dimensional, context-dependent, population-
based instruments for measuring ECD.
The Package has a number of strengths. First, is its ability to assess multiple
dimensions of neurodevelopment in preschoolers without the need for specialist
staff or infrastructure. Second, the package was designed to reduce cultural and
language biases in its administration as much as possible, thus making it suitable
for use among children from middle- and upper class families across low-,
middle- and high-income settings. This was done by selecting a pool of items
using a decentering approach which, to the best of the Group’s knowledge,
involved resources that were familiar to children from middle- and upper-class
families across settings and were not affected by cultural and language biases. The
Group also adopted a scoring system based on objective observations of the child’s
performance rather than subjective judgments and undertook a process of cultural
customization during on-site training sessions. Third, non-specialist field workers
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can easily deliver the Package in 35–45 minutes, and integrated quality checks in
tablet-based application ensure that data can be collected reliably across diverse
settings and contexts. An added feature of the Package is that its constituent
assessments measure the function of entire vision and auditory pathways and not
merely specific components.
There are a number of methodological and conceptual limitations to consider.
First, the selection of tools for the Package was based on an overview of existing
well-established instruments to assess ECD in preschoolers. This process consisted
of a systematic review of the literature and discussions with experts, and not on a
meta-analysis of existing tools, which might have produced a more objective
assessment. The results of this process resulted in a list of, to our knowledge, the
most well-established psychometric tools to assess children at 2 years of age but we
acknowledge that this list is not exhaustive. In addition, the results of the
systematic review were not evaluated against the PRISMA or STROBE guidelines
[54, 55] because our primary concern was not the quality of the individual studies
but the suitability of the instrument for the Project. Second, it may appear that the
INTER-NDA is based on a variety of items from a number of different tools.
However, all items are conceptually equivalent to those in the candidate measures
and were carefully selected by international experts for the purpose of the study
and the tool’s future potential as a population-based screening instrument of
ECD. Third, the INTER-NDA is not yet available in all the languages of the
participating study sites, although translations are being prepared in accordance
with the WHO Mental Health Initiative translation guidelines [56]. The Package
was designed specifically for the 22 to 26 month age group and should not be
used, therefore, in other age groups. Fourth, the tool was designed for use among
children from middle- and upper class families, and its usefulness needs to be
assessed in children from poorer backgrounds. Lastly, the Package does not assess
the nature and degree of the concerns of caregivers about their children in detail.
Conclusions
To the best of our knowledge, the Package represents the first attempt at a concise,
yet comprehensive, multi-dimensional instrument to measure early child
development by non-specialist field workers across low- middle- and high-income
settings. The comprehensiveness of the Package, its mixed methodology approach
and ease of use make it a good candidate for scalability in the context of
population-based research, as well as for screening purposes. This paper describes
the current landscape of well-established psychometric tools to measure ECD in
preschoolers and outlines the methodological approach of systematic evaluation
and tool selection, which led to the development of the Package. We believe this
approach may be of use to persons and organizations involved in large-scale
efforts in ECD research and surveillance when selecting and/or developing
measures of ECD.
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